BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34709943)

  • 21. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up.
    Rodriguez-Wallberg KA; Marklund A; Lundberg F; Wikander I; Milenkovic M; Anastacio A; Sergouniotis F; Wånggren K; Ekengren J; Lind T; Borgström B
    Acta Obstet Gynecol Scand; 2019 May; 98(5):604-615. PubMed ID: 30723910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elective and Onco-fertility preservation: factors related to IVF outcomes.
    Cobo A; García-Velasco J; Domingo J; Pellicer A; Remohí J
    Hum Reprod; 2018 Dec; 33(12):2222-2231. PubMed ID: 30383235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of fertility preservation outcomes in patients who froze oocytes, embryos, or ovarian tissue for medically indicated circumstances: a systematic review and meta-analysis.
    Ní Dhonnabháin B; Elfaki N; Fraser K; Petrie A; Jones BP; Saso S; Hardiman PJ; Getreu N
    Fertil Steril; 2022 Jun; 117(6):1266-1276. PubMed ID: 35459522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients.
    Sanada Y; Harada M; Kunitomi C; Kanatani M; Izumi G; Hirata T; Fujii T; Suzuki N; Morishige KI; Aoki D; Irahara M; Tsugawa K; Tanimoto M; Nishiyama H; Hosoi H; Sugiyama K; Kawai A; Osuga Y
    J Obstet Gynaecol Res; 2019 Oct; 45(10):2021-2028. PubMed ID: 31364239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.
    Lyttle Schumacher B; Grover N; Mesen T; Steiner A; Mersereau J
    Hum Reprod; 2017 Oct; 32(10):2049-2055. PubMed ID: 28938728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transgender men's experiences of fertility preservation: a qualitative study.
    Armuand G; Dhejne C; Olofsson JI; Rodriguez-Wallberg KA
    Hum Reprod; 2017 Feb; 32(2):383-390. PubMed ID: 27999119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of boys who have undergone a testicular biopsy for fertility preservation.
    Kanbar M; de Michele F; Giudice MG; Desmet L; Poels J; Wyns C
    Hum Reprod; 2021 Jan; 36(1):26-39. PubMed ID: 33259629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Participation of Pediatric Surgery Training Programs in Fertility Preservation Initiatives.
    Harris CJ; Corkum KS; Laronda MM; Rowell EE
    J Laparoendosc Adv Surg Tech A; 2020 Sep; 30(9):1018-1022. PubMed ID: 32559397
    [No Abstract]   [Full Text] [Related]  

  • 29. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
    Danis RB; Pereira N; Elias RT
    Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single center.
    Poirot C; Brugieres L; Yakouben K; Prades-Borio M; Marzouk F; de Lambert G; Pacquement H; Bernaudin F; Neven B; Paye-Jaouen A; Pondarre C; Dhedin N; Drouineaud V; Chalas C; Martelli H; Michon J; Minard V; Lezeau H; Doz F; Sarnacki S; Philippe-Chomette P; Dufour C; Laurence V; Baruchel A; Wolf JP; Boissel N; Valteau-Couanet D; Dalle JH
    Acta Obstet Gynecol Scand; 2019 May; 98(5):630-637. PubMed ID: 30919447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience.
    Mayeur A; Puy V; Windal V; Hesters L; Gallot V; Benoit A; Grynberg M; Sonigo C; Frydman N
    J Assist Reprod Genet; 2021 Jul; 38(7):1767-1775. PubMed ID: 33797007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fertility Preservation for Transgender Adolescents.
    Chen D; Simons L; Johnson EK; Lockart BA; Finlayson C
    J Adolesc Health; 2017 Jul; 61(1):120-123. PubMed ID: 28363716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation.
    Letourneau JM; Wald K; Sinha N; Juarez-Hernandez F; Harris E; Cedars MI; McCulloch CE; Dolezal M; Chien AJ; Rosen MP
    Cancer; 2020 Feb; 126(3):487-495. PubMed ID: 31639215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survey of young women with breast cancer to identify rates of fertility preservation (FP) discussion and barriers to FP care.
    Sauerbrun-Cutler MT; Pandya S; Recabo O; Raker C; Clark MA; Robison K
    J Assist Reprod Genet; 2023 Aug; 40(8):2003-2011. PubMed ID: 37329421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A nationwide UK survey of female fertility preservation prior to cancer treatment.
    Abdallah Y; Briggs J; Jones J; Horne G; Fitzgerald C
    Hum Fertil (Camb); 2018 Apr; 21(1):27-34. PubMed ID: 28545332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fertility preservation for transgender adolescents and young adults: a systematic review.
    Baram S; Myers SA; Yee S; Librach CL
    Hum Reprod Update; 2019 Nov; 25(6):694-716. PubMed ID: 31633751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
    Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
    Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Experience of Fertility Preservation in a Single Tertiary Center in Korea.
    Choi YJ; Hong YH; Kim S; Kim SK; Lee JR; Suh CS
    Front Endocrinol (Lausanne); 2022; 13():845051. PubMed ID: 35518927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
    Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
    Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
    Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
    Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.